MALAT1 and pancreatic neoplasm: To verify the role of MALAT1 in pancreatic tumours, we knocked down MALAT1 in Panc-1 and Aspc-1 cells using two siRNAs (siMALAT1-1 and siMALAT1-2) to avoid off-target effects.